Long-acting GnRH analogue triptorelin therapy in central isosexual precocious puberty

Indian Pediatrics

Volumn 39, Issue 7, 2002, Pages 633-639

  Bajpai, Anurag ^a   Sharma, Jyoti ^a   Kabra, Madhulika ^a   Gupta, Arun K ^a   Menon, P S N ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

GnRH analogue; Precocious puberty; Triptorelin

Indexed keywords

FOLLITROPIN; GONADORELIN DERIVATIVE; LUTEINIZING HORMONE; TRIPTORELIN;

ARTICLE; BODY HEIGHT; CHILD; CHILD GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HORMONAL THERAPY; HUMAN; MALE; PRECOCIOUS PUBERTY;

CHILD; CHILD, PRESCHOOL; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; INFANT; LUTEOLYTIC AGENTS; MALE; PUBERTY, PRECOCIOUS; TRIPTORELIN;

EID: 0036073899     PISSN: 00196061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Lee PA. Medroxyprogesterone therapy for sexual precocity in girls. Am J Dis Child 1981; 8: 443-445.
2. Laron Z, Kauli R. Experience with cyproterone acetate in the treatment of precocious puberty. J Pediatr Endocrinol Metab 2000; 13 (Suppl 1): 805-810.
3. Antoniazzi F, Cisternino M, Nizzoli G, Bozzola M, Corrias A, De Luca F, et al. Final height in girls with central precocious puberty: comparison of two different luteinizing hormone-releasing hormone agonist treatments. Acta Pediatr 1994; 83: 1052-1056.
4. Lee PA. Central precocious puberty: An overview of diagnosis, treatment and outcome. Endo Clin N Am 1999; 28: 901-918.
5. Oostdijk W, Hummelink R, Odnik RJH, Partsch CJ, Drop SLS, Lorenzen F, et al. Treatment of children with central precocious puberty by a slow-release GnRH agonist. Eur J Pediatr 1990; 149: 308-313.
6. Cassio A, Cacciari E, Balsamo A, Bal M, Tasssinari D. Randomized trial of LHRH analogue treatment on final height in girls with onset of puberty aged 7.5 - 8.5 years. Arch Dis Child 1999; 81: 329-332.
7. Oostdijk W, Rikken B, Schreuder S, Otten B, Odnik R, Rouwe C, et al. Final height in central precocious puberty after long-term treatment with a slow release GnRH agonist. Arch Dis Child 1996; 75: 292-297.
8. Partsch CJ, Heger S, Sippell WG. Treatment of central precocious puberty: lessons from a 15 years prospective trial. J Ped Endo Metab 2000; 13: 747-758.
9. Bouvattier C, Coste J, Rodrigue D, Teinturier C, Carel JC, Chaussain JL, et al. Lack of effect of GnRH agonists on final height in girls with advanced puberty: a randomized long-term pilot study. J Clin Endocrinol Metab 1999; 84: 3575-3578.
10. Arrigo T, Cisternono M, Galluzzi F, Bertelloni S, Pasquino AM, Antoniazzi F, et al. Analysis of the factors affecting auxological response to GnRH agonist treatment and final height outcome in girls with idiopathic central precocious puberty. Eur J Endocrinol 1999; 141: 140-144.
11. Micillo M, Salreno M, Officioso A, Perna E, Gasparini N, Pisaturo L, et al. Near final height after GnRH agonist treatment in central precocious puberty. J Ped Endo Metab, 2000; 13: 787-790.
12. Carel JC, Roger M, Ispas S, Tondu F, Lahlou N, Blumberg J, et al. Final height after long-term treatment with triporelin slow release for central precocious puberty: importance of statural growth after interruption of treatment. J Clin Endcrinol Metab 1999; 84: 1973-1978.
13. Tanner JM. Growth at Adolescence, 11th edn. Oxford, Blackewell Scientific, 1962.
14. 2 method). London, Academic press, 1983.
15. Bayley N, Pinneau SR. Tasbles for predicting adult height from skeletal age: revised use with Greulich-Pyle hand standards. J Pediatr 1952; 40: 423-441.
16. Kauli R, Galatzer A, Kornreich L, Lazar L, Pertzelan A, Laron Z. Final height of girls with central precocious puberty, untreated versus treated with cyproterone acetate or GnRH analogue. A comparative study with reevaluation of predictions by the Bayley-Pinneau method. Horm Res 1997; 47: 54-61.
17. Tanner JM, Whitehouse RH, Takiashi M. Standards from birth to maturity for height, weight, height velocity and weight velocity: British children. Arch Dis Child 1996; 41: 613-635.
18. Lughetti L, Predieri B, Ferrari M, Gallo C, Livio L, Milioni S, et al. Diagnosis of precocious puberty: Endocrine assessment. J Ped Endo Metab 2000; 13: 709-715.
19. Antoniazzi F, Arrigo T, Cisternio M, Galluzi F, Bertelloni S, Pasquino AM, et al. End results in central precocious puberty with GnRH analog treatment: the data of the Italian study group for pathophysiology of puberty. J Ped Endo Metab 2000; 13: 773-780.
20. Mul D, Oostdijk W, Otten BJ, Rouwe C, Jansen M, VandeWaal HAD, et al. Final height after gonadotropin releasing hormone agonist treatment for central precocious puberty: Dutch experience. J Ped Endo Metab 2000; 13: 765-772.
21. Bertelloni S, Baroncelli GI, Sorrentino MC, Perri G, Saggese G. Effect of central precocious puberty and gonadotropin-releasing hormone analogue treatment on peak bone mass and final height in females. Eur J Pediatr 1998; 157: 363-367.
22. Manasco PK, Pescotitx OH, Hill SC, Jones JM, Barnes KM, Hench KD, et al. Six-year results of lutenizing hormone releasing hormone (LHRH) agonist treatment in children with LHRH dependent precocious puberty. J Pediatr 1989; 115: 105-108.
23. Leger J, Reynaud R, Czernichow P. Do all girls with apparent idiopathic precocious puberty require gonadotropin-reieasing hormone agonist treatment? Pediatr 2000; 137: 819-825.
24. Brauner R, Malandry F, Rappaport R. Predictive factors for the effect of gonadotrophin releasing hormone analogue therapy on the height of girls with idiopathic central precocious puberty. Eur J Pediatr 1992; 151: 728-730.
25. Oerter KE, Manasco P, Barnes KM, Jones J, Hill S, Culter GB Jr. Adult height in precocious puberty after long-term treatment with deslorelin. J Clin Endo Metab 1991; 73: 1235-1240.
26. Paul D, Conte FA, Grumbach MM, Kaplan SL. Long-term effect of gonadotropin-releasing hormone agonist therapy on final and near final height in 26 children with true precocious puberty treated at a median age of less than 5 years. J Clin Endocrinol Metab 1995; 80: 546-551.
27. Rizzo V, Desanctis V, Corrias A, Fortni M, Galluzzi F, Betelloni S, et al. Factors influencing Final/near-final height in 12 boys with central precocious puberty treated with gonadotrophin-releasing hormone agonists. Italian Study Group of Physiopathology of Puberty. J Ped Endo Metab 2000; 13: 781-786.